Swati Parekh, MD
Ophthalmology · Woodland Park, NJNPI 1427087725
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $24,865 of the $40,551 with a category attached, or 61.3%. 38 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 41.1% of the total. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 607 payments — averaging $66.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$17K
- AbbVie$4K
- Sight Sciences, Inc.$3K
- NEW World Medical,inc.$3K
- Glaukos Corporation$2K
- Johnson & Johnson Surgical Vision, Inc.$2K
- plus $10K from 32 others
What the payments were for
- Consulting fees$15,52838%
- Travel & lodging$930%
- Food & beverage$24,86561%
- Education$650%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- enVista Aspire IOL$5,671
- MIEBO$4,246
- XIIDRA$4,114
- enVista MX60 IOL$1,884
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$1,605
- OMNI(R) SURGICAL SYSTEM (US)$1,561
- DURYSTA$1,418
- DEXYCU$1,317
- Tecnis IOL$933
- Ahmed Glaucoma Valve$857
- Kahook Dual Blade$857
- One Series Ultra$803
- SION SURGICAL INSTRUMENT$794
- Clareon$523
- Tecnis Simplicity$512
- Clearpath$447
- Streamline$447
- XDEMVY$387
- RXSIGHT CONTACT LENS$366
- RXSIGHT INJECTOR CARTRIDGE$366
How this compares
$40,551 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 300 | $295,112 |
| LumiganBimatoprost | 323 | $143,835 |
| Cyclosporine | 195 | $130,366 |
| XiidraLifitegrast | 111 | $126,814 |
| CequaCyclosporine | 30 | $32,330 |
| RocklatanNetarsudil Mesylat/Latanoprost | 58 | $20,537 |
| VyzultaLatanoprostene Bunod | 39 | $20,068 |
| CombiganBrimonidine Tartrate/Timolol | 52 | $18,270 |
| Restasis MultidoseCyclosporine | 19 | $17,025 |
| MieboPerfluorohexyloctane/Pf | 18 | $13,453 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 57 | $9,743 |
| RhopressaNetarsudil Mesylate | 14 | $5,431 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 28 | $5,170 |
| ZerviateCetirizine Hcl | 14 | $4,894 |
| LotemaxLoteprednol Etabonate | 14 | $4,575 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Restasis Multidose, Alphagan P | $4,035 | $478,243709 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta, Miebo | $16,658 | $160,336168 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $324 | $32,33030 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $532 | $25,96972 claims |
| AlconSimbrinza | $1,337 | $5,17028 claims |
| Eyevance Pharmaceuticals LLCZerviate | $256 | $4,89414 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax | $215 | $4,57514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Woodland Park
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
- Robert FechtnerNewark$324K
- Rajen DesaiFreehold$311K
- Douglas GraysonIselin$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.